{"id":55925,"date":"2020-11-11T07:21:32","date_gmt":"2020-11-11T07:21:32","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=55925"},"modified":"2022-02-16T09:11:40","modified_gmt":"2022-02-16T09:11:40","slug":"cardiac-glycoside","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/","title":{"rendered":"Cardiac glycoside"},"content":{"rendered":"<p>A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.<\/p>\n<hr \/>\n<p>A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.<\/p>\n<hr \/>\n<p>Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle. A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin. Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-55925","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cardiac glycoside - Definition of Cardiac glycoside<\/title>\n<meta name=\"description\" content=\"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiac glycoside - Definition of Cardiac glycoside\" \/>\n<meta property=\"og:description\" content=\"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-11T07:21:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-16T09:11:40+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/\",\"name\":\"Cardiac glycoside - Definition of Cardiac glycoside\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-11-11T07:21:32+00:00\",\"dateModified\":\"2022-02-16T09:11:40+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiac glycoside\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiac glycoside - Definition of Cardiac glycoside","description":"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/","og_locale":"en_US","og_type":"article","og_title":"Cardiac glycoside - Definition of Cardiac glycoside","og_description":"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/","og_site_name":"Glossary","article_published_time":"2020-11-11T07:21:32+00:00","article_modified_time":"2022-02-16T09:11:40+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/","name":"Cardiac glycoside - Definition of Cardiac glycoside","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-11-11T07:21:32+00:00","dateModified":"2022-02-16T09:11:40+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A drug related to digitalis that is used to slow the heart rate and to increase the force of the contraction of the cardiac muscle.A drug used in the treatment of tachycardia and atrial fibrillation, e.g. digoxin.Drugs whose main actions are to increase the force of myocardial contraction and reduce the conductivity of the nerve fibres in the atrioventricular node of the heart. They are useful in treating supraventricular tachycardias (rapid heart rhythm) and some forms of heart failure. Glycosides are a traditional group of cardiac drugs, originally derived from the leaves of foxglove plants and used as digitalis. The active principle has long been synthesised and used as digoxin. They are potentially toxic and their use, especially during initial treatment, should be monitored. Side-effects include anorexia, nausea, vomiting, diarrhoea and abdominal pain; drowsiness, confusion and depression may occur. An abnormally slow heart rate may develop. The glycosides should be used with special care in the elderly, who are sometimes particularly susceptible to their toxic effects.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/cardiac-glycoside\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Cardiac glycoside"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/55925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=55925"}],"version-history":[{"count":4,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/55925\/revisions"}],"predecessor-version":[{"id":146422,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/55925\/revisions\/146422"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=55925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=55925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=55925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}